Global Health Crisis: Key Updates on Mpox, Parent Stress, and New Drug Developments

The current health news highlights issues ranging from the mpox virus increasing fiscal pressures in sub-Saharan Africa to U.S. Surgeon General addressing parent stress as a public health challenge. Also covered are drug developments for schizophrenia, challenges in tracking a new mpox strain in Africa, and the failure to sell Mundipharma's China unit.

Following is a summary of current health news briefs.

The rapid spread of the mpox virus in sub-Saharan Africa could exacerbate existing fiscal pressures, according to a warning from credit rating agency Fitch. The clade Ib strain, declared a global health emergency earlier this month, has spread from the Democratic Republic of Congo to neighboring countries.

Drugmaker Mundipharma International, despite being owned by the affluent Sackler family, has failed for the second time to offload its China unit. Hired by Deutsche Bank, the company aimed to sell the unit for over $1 billion.

U.S. Surgeon General Vivek Murthy on Wednesday issued an advisory on the modern stresses impacting parents' mental health. He called for increased resources from the government, businesses, and community organizations to support parents and caregivers more effectively.

Africa’s scientists are struggling to track a new, rapidly mutating strain of mpox, reported experts across multiple continents. Due to a lack of funding and equipment, many uncertainties remain about the virus's severity and transmission.

Neurocrine Biosciences announced its schizophrenia drug candidate, NBI-1117568, met the main study goals in a mid-stage trial. The drug significantly reduced schizophrenia symptoms at a 20-milligram dose compared to a placebo.

Spain will contribute 500,000 doses of the mpox vaccine to Africa's outbreak, amounting to 20% of its reserves, the Health Ministry reported. Spain has also encouraged EU member states to donate a similar percentage of their vaccine stocks.

The U.S. CDC reported 21 cases of Oropouche virus among travelers returning from Cuba. Spread by midges and some mosquitoes, the virus causes fever, muscle aches, and joint pain but is rarely fatal.

Delaware's highest court will hear an appeal from drugmakers, including GSK and Pfizer, aiming to end over 70,000 lawsuits linked to the heartburn drug Zantac alleging that it causes cancer.

Eli Lilly has launched the lowest starter dose of its weight-loss drug Zepbound at $399 per month to enhance accessibility. Typically sold in auto-injector pens, the lower-cost vials could improve market availability.

New Hampshire reported its first human death from Eastern equine encephalitis virus (EEEV) in a decade. The mosquito-borne disease claimed the life of an adult resident from Hampstead, marking the fifth U.S. case this summer.